Donnerstag, 24. Februar 2011

Sanofi-Aventis to buy Genzyme for $20.1 bln cash (AP)

FILE - In this May 28, 2008 file photo, Genzyme's Manufacturing Facility is seen in the Allston neighborhood of Boston. French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion Wednesday, Feb. 16, 2011, ending months of corporate haggling.(AP Photo/Bizuayehu Tesfaye, file)AP - French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash $20.1 billion deal that ends months of corporate haggling and positions Sanofi at the forefront of the market in lucrative drugs for rare genetic disorders.


Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/ap/20110216/ap_on_he_me/eu_sanofi_aventis_genzyme

mesothelioma settlements pericardial mesothelioma lung mesothelioma

Eingestellt von um

Keine Kommentare:

Kommentar veröffentlichen

Abonnieren Kommentare zum Post (Atom)